LEIDEN JEFFREY M

CIK 00012428255 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001242825

Recent Transactions

50 trades

Exercise/Conversion
Odyssey Therapeutics, Inc.$ODTX
Series D Warrants (Right to Buy)
2026-05-11−28,800→ 0 total
Conversion
Odyssey Therapeutics, Inc.$ODTX
Common Stock
2026-05-11+28,698→ 28,698 total
Conversion
Odyssey Therapeutics, Inc.$ODTX
Series D Convertible Preferred Stock
2026-05-11−96,002→ 0 total
Exercise/Conversion
Odyssey Therapeutics, Inc.$ODTX
Common Stock
2026-05-11+2,963→ 31,661 total
Tax Payment
Odyssey Therapeutics, Inc.$ODTX
Common Stock
2026-05-11$18.00/sh−17→ 31,644 total
Conversion
Odyssey Therapeutics, Inc.$ODTX
Series B Convertible Preferred Stock
2026-05-11−79,166→ 0 total
Conversion
Odyssey Therapeutics, Inc.$ODTX
Series C Convertible Preferred Stock
2026-05-11−100,000→ 0 total
Purchase
Odyssey Therapeutics, Inc.$ODTX
Common Stock
2026-05-08$20.00/sh+5,000→ 270,198 total
Award
Odyssey Therapeutics, Inc.$ODTX
Stock Option (Right to Buy)
2026-05-07+626,220→ 626,220 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-24$485.11/sh−3,547→ 34,797 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-18$483.75/sh−2,964→ 38,344 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-17+8,269→ 41,308 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-01-22+9,012→ 33,039 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-12-04−1→ 0 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-04$91.05/sh+1→ 24,027 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$448.78/sh−2,320→ 63,826 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$447.05/sh−1,152→ 66,146 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$445.56/sh−7,899→ 67,298 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$443.21/sh−2,469→ 79,549 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$441.26/sh−1,320→ 82,018 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$440.40/sh−4,469→ 83,338 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$449.84/sh−5,880→ 57,946 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$86.52/sh+63,781→ 87,807 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$455.22/sh−2,070→ 24,026 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-12-03−63,781→ 0 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$444.36/sh−4,352→ 75,197 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$453.34/sh−10,360→ 26,096 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$452.20/sh−15,681→ 36,456 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-12-03$451.20/sh−5,809→ 52,137 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-11-14−39,769→ 63,781 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-14$440.30/sh−32,234→ 45,396 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-14$86.52/sh+39,769→ 77,630 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-14$442.00/sh−40→ 24,026 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-14$441.35/sh−21,330→ 24,066 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-14$91.05/sh+13,835→ 37,861 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-11-14−13,835→ 1 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-13$91.05/sh+19,688→ 43,714 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option (Right to Buy)
2025-11-13−19,688→ 13,836 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-13$441.05/sh−1,160→ 24,026 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-13$440.22/sh−18,528→ 25,186 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-14$463.46/sh−6,066→ 24,026 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-13$450.83/sh−2,525→ 30,092 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-12+7,209→ 32,617 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-04+15,414→ 25,408 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-08-30$499.00/sh−3,784→ 9,994 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-20$420.58/sh−4,118→ 13,778 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-15$419.16/sh−4,655→ 17,896 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-14$419.04/sh−4,356→ 22,551 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-13$419.13/sh−737→ 26,907 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-12$420.39/sh−647→ 27,644 total

Companies

Recent Filings

Address

C/O ODYSSEY THERAPEUTICS, INC. 51 SLEEPER STREET, SUITE 800

BOSTON, MA, 02210

View on SEC.gov